Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 119

Sort by

Sort Order Select

Journal Articles

Immunophenotypic Patterns of Bone Marrow Eosinopoiesis in Patients with Hypereosinophillic Syndrome and Systemic Mastocytosis

Christopher Trindade, MD, Xiaoping Sun, PhD, Dragan Maric, PhD, Chunjie Jiang, Christopher S. Hourigan, DPhil FACP FRCP, Dean D. Metcalfe, MD, Amy Klion, MD, Irina Maric, MD MSci

Blood (2018) 132 (Supplement 1): 4294.

https://doi.org/10.1182/blood-2018-99-118797

Published: 2018

Journal Articles

Characterization of a Mouse Model of Hypereosinophilic Syndrome

Nives Zimmermann, MD, William J Gibbons, Jr., Shelli M Homan, Andrea Klingler, Daniel R Prows, PhD

Blood (2018) 132 (Supplement 1): 3686.

https://doi.org/10.1182/blood-2018-99-113909

Published: 2018

Journal Articles

All Itching Is Not Benign; A Case of Refractory Hypereosinophilic Syndrome Treated with Off Label CD52 Inhibitor-Alemtuzumab

Rehan Ansari, MD, Elva Nora Osuna Salazar, MD, Nabeel Sarhill, MD, Laura E Garcia, MD, James Hanley, MD

Blood (2018) 132 (Supplement 1): 5485.

https://doi.org/10.1182/blood-2018-99-118271

Published: 2018

Journal Articles

NOTCH Activation at the Definitive Mesoderm Stage Facilitates Efficient Generation of T Cells with High Proliferation Potential from Human Pluripotent Stem Cells

Akhilesh Kumar, PhD, Kran Suknuntha, MDPhD, Saritha S D'souza, PhD, Jeong Hee Lee, MS, Andres Grandea, PhD, Abhir S Thakur, David T Evans, PhD, Igor Slukvin, MDPhD

Blood (2017) 130 (Supplement 1): 3185.

https://doi.org/10.1182/blood.V130.Suppl_1.3185.3185

Published: 2017

Journal Articles

Aautoimmune Hemolytic Anemia: Pattern of Clinical Presentation and Management Outcome — a Nine Year Observation from a Tertiary Care Hospital in Saudi Arabia

Mahsen AlSaleh, MD, Tarek Owaidah, MD, Abdullah AlJefri, MD, Saba Parween, MBBS, Roula Barmada, MD, Silgy Jose, RN, Bouchra Safi, RN, Viqaruddin Mohammed, MSc, CCRP, Joumana AlEita, MD

Blood (2017) 130 (Supplement 1): 4744.

https://doi.org/10.1182/blood.V130.Suppl_1.4744.4744

Published: 2017

Journal Articles

Human Immunodeficiency Virus (HIV) Status Drives Diffuse Large B Cell Lymphoma through Oncogenic Signaling Pathways

Alanna Maguire, BSc, MSc, PhD, Gary B Fogel, PhD, Samantha L. Kendrick, PhD, Enoch S Liu, B.S., Lee Wisner, A.A., Colleen Ramsower, B.S. M.B., Betty Glinsmann-Gibson, MS, Susanna L Lamers, M.S., Michael S. McGrath, MD PhD, Lisa M. Rimsza, MD

Blood (2017) 130 (Supplement 1): 5128.

https://doi.org/10.1182/blood.V130.Suppl_1.5128.5128

Published: 2017

Journal Articles

Engineering of Induced Pluripotent Stem Cell-Derived Hemogenic Endothelium

Jerry Lee, MPhil, MS, Ryohichi Sugimura, MD PhD, George Q Daley, MD PhD

Blood (2017) 130 (Supplement 1): 2424.

https://doi.org/10.1182/blood.V130.Suppl_1.2424.2424

Published: 2017

Journal Articles

A Novel JAK2 Mutation Confers Cytokine-Independence in the Absence of a Type I Dimeric Cytokine Receptor

Ami B. Patel, MD, Anca Franzini, PhD, Emilie Leroy, PhD, Dongqing Yan, Anna M. Eiring, PhD, Stefan N. Constantinescu, MD PhD, Thomas O'Hare, PhD, Michael W. Deininger, MD PhD

Blood (2017) 130 (Supplement 1): 4212.

https://doi.org/10.1182/blood.V130.Suppl_1.4212.4212

Published: 2017

Journal Articles

Increased Prevalence of t(8;9)(p21-23;p23-24) Translocations within 9p24 Abnormalities in Patients with Myeloid Malignancies Identified from the Mitelman Database

Matthew K Stein, MD, Dilan Patel, MD, Andrew Hahn, MD, Jamie Riney, MD, Michael G. Martin, MD

Blood (2016) 128 (22): 1935.

https://doi.org/10.1182/blood.V128.22.1935.1935

Published: 2016

Journal Articles

Tumor Markers in Diagnosis and Follow up of Haematologic Malignancies

Zisis Kontoninas, MD PhD, Georgia D Kaiafa, MD PhD, Zoi Saouli, MD PhD Haematologist, Christos G Savopoulos, Associate Prof of Internal MDcine, Didangelos Triantafyllos, Assistant Prof of Internal MDcine, Achilles Anagnostopoulos, Apostolos I Hatzitolios, Professor of Internal MDcine, Athanasios Papadopoulos, Professor of Haematology

Blood (2016) 128 (22): 5337.

https://doi.org/10.1182/blood.V128.22.5337.5337

Published: 2016

Journal Articles

Ruxolitinib Used to Treat Hypereosinophilic Syndrome

Seung Lee, bs, Coby Palmares, Niko Koutsoukos, J. Brice Weinberg, MD, Trisa Palmares, MD, Alice Song, MD, Harold Song, MD, Sheila Benedicto, bs, Michael Song, bs, Vu Phan, MD, Julia Song, MD

Blood (2016) 128 (22): 5500.

https://doi.org/10.1182/blood.V128.22.5500.5500

Published: 2016

Journal Articles

Experience with Pegylated Interferon α-2a in 30 Patients Diagnosed with Hematologic Neoplasms

Adile Begum Bahcecioglu, Sezgin Etgul, Tuncay Aslan, Muruvvet Seda Aydın, Umit Yavuz Malkan, Mufide Okay, Evren Ozdemir, MD, Rafiye Ciftciler, Hakan Goker, MD, Yahya Buyukasik, MD

Blood (2016) 128 (22): 5483.

https://doi.org/10.1182/blood.V128.22.5483.5483

Published: 2016

Journal Articles

Lymphocytic variant of hypereosinophilic syndrome mimicking peripheral T-cell lymphoma in a young woman

Rebecca L. King, Matthew T. Howard

Blood (2016) 127 (2): 268.

https://doi.org/10.1182/blood-2015-10-674945

Published: 2016

Journal Articles

An Unusual Case of Hypereosinophilic Syndrome

Anwarul Islam, MD

Blood (2014) 124 (21): 4965.

https://doi.org/10.1182/blood.V124.21.4965.4965

Published: 2014

Journal Articles

Blood Traffic of Endothelial, Mesenchymal, Hematopoietic and Lin-/CD45-CD34+AC133+CXCR4+ Progenitor Cell Subsets Show Different Patterns in Pre-Fibrotic and Fibrotic Primary Myelofibrosis

Mario Ojeda-Uribe, MD, Christophe Desterke, PhD, Laura Jung, PhD, Pierre Bories, MD, Hanna Sovalat, PhD, Laurent Mauvieux, MD PhD, Jean Claude Eisenmann, Bruno Lioure, Marie-Caroline Le Bousse-Kerdiles, PhD

Blood (2014) 124 (21): 3230.

https://doi.org/10.1182/blood.V124.21.3230.3230

Published: 2014

Journal Articles

Midostaurin (PKC412) Demonstrates a High Rate of Durable Responses in Patients with Advanced Systemic Mastocytosis: Results from the Fully Accrued Global Phase 2 CPKC412D2201 Trial

Jason Gotlib, MD MS, Hanneke C. Kluin-Nelemans, MD PhD, Tracy I. George, MD, Cem Akin, MD PhD, Karl Sotlar, MD, Olivier Hermine, MD PhD, Farrukh Awan, MD MS, Elizabeth O Hexner, MD, Michael Mauro, MD, David Sternberg, MD PhD, Matthieu Villeneuve, Fabienne Emery-Salbert, MSc, Eric Stanek, PharmD, Karin Hartmann, MD, Hans-Peter Horny, MD, Peter Valent, MD, Andreas Reiter, MD

Blood (2014) 124 (21): 636.

https://doi.org/10.1182/blood.V124.21.636.636

Published: 2014

Journal Articles

Therapy-Related Myeloid Neoplasms: Report Of The Italian Network On Secondary Leukemias

Blood (2013) 122 (21): 2659.

https://doi.org/10.1182/blood.V122.21.2659.2659

Published: 2013

Journal Articles

SL-401, a Targeted Therapy Directed To The Interleukin-3 Receptor (IL-3R), Possesses Preclinical Cytotoxic Activity Against Chronic Eosinophilic Leukemia

Christopher Brooks, PhD, Vincent Macri, Arnaldo Albini, MD, Ivan Bergstein, MD, Eric Rowinsky, MD

Blood (2013) 122 (21): 4104.

https://doi.org/10.1182/blood.V122.21.4104.4104

Published: 2013

Journal Articles

Spi-C Negatively Regulates Murine Eosinophil Differentiation

Kaila L Schollaert, MA, Michael R Stephens, Melissa K. Mingler, MBA, Marc E. Rothenberg, MD, PhD, Patricia C. Fulkerson, MD, PhD

Blood (2013) 122 (21): 2273.

https://doi.org/10.1182/blood.V122.21.2273.2273

Published: 2013

Journal Articles

Bloodstream Progenitor-Cell Traffic In Primary Myelofibrosis Reveals Cell Subsets Showing Some Features Of Very-Small Embryonnic-Like Stem Cells (VSELs), Along With Endothelial (PEC), Mesenchymal (MPC) and Hematopoietic (HPC) Progenitor Cells

Mario Ojeda-Uribe, MD, Hanna Sovalat, PhD, Laura Jung, PhD, Christophe Desterke, PhD, Sylvie Thiebault, MD, Pierre Bories, MD, Laurent Mauvieux, MD, PhD, Philippe Tropel, PhD, Jean-Claude Eisenmann, MD, Bruno Lioure, MD, Anne-Claire Voegeli, PhD, Eric Jeandidier, MD, Stephane Viville, PharmD, PhD, Valerie Rimelen, PhD, Marie-Caroline Le Bousse-Kerdiles, PhD

Blood (2013) 122 (21): 5265.

https://doi.org/10.1182/blood.V122.21.5265.5265

Published: 2013

NARROW

Immunophenotypic Patterns of Bone Marrow Eosinopoiesis in Patients with Hypereosinophillic Syndrome and Systemic Mastocytosis

Characterization of a Mouse Model of Hypereosinophilic Syndrome

All Itching Is Not Benign; A Case of Refractory Hypereosinophilic Syndrome Treated with Off Label CD52 Inhibitor-Alemtuzumab

NOTCH Activation at the Definitive Mesoderm Stage Facilitates Efficient Generation of T Cells with High Proliferation Potential from Human Pluripotent Stem Cells

Aautoimmune Hemolytic Anemia: Pattern of Clinical Presentation and Management Outcome — a Nine Year Observation from a Tertiary Care Hospital in Saudi Arabia

Human Immunodeficiency Virus (HIV) Status Drives Diffuse Large B Cell Lymphoma through Oncogenic Signaling Pathways

Engineering of Induced Pluripotent Stem Cell-Derived Hemogenic Endothelium

A Novel JAK2 Mutation Confers Cytokine-Independence in the Absence of a Type I Dimeric Cytokine Receptor

Increased Prevalence of t(8;9)(p21-23;p23-24) Translocations within 9p24 Abnormalities in Patients with Myeloid Malignancies Identified from the Mitelman Database

Tumor Markers in Diagnosis and Follow up of Haematologic Malignancies

Ruxolitinib Used to Treat Hypereosinophilic Syndrome

Experience with Pegylated Interferon α-2a in 30 Patients Diagnosed with Hematologic Neoplasms

Lymphocytic variant of hypereosinophilic syndrome mimicking peripheral T-cell lymphoma in a young woman

An Unusual Case of Hypereosinophilic Syndrome

Blood Traffic of Endothelial, Mesenchymal, Hematopoietic and Lin-/CD45-CD34+AC133+CXCR4+ Progenitor Cell Subsets Show Different Patterns in Pre-Fibrotic and Fibrotic Primary Myelofibrosis

Midostaurin (PKC412) Demonstrates a High Rate of Durable Responses in Patients with Advanced Systemic Mastocytosis: Results from the Fully Accrued Global Phase 2 CPKC412D2201 Trial

Therapy-Related Myeloid Neoplasms: Report Of The Italian Network On Secondary Leukemias

SL-401, a Targeted Therapy Directed To The Interleukin-3 Receptor (IL-3R), Possesses Preclinical Cytotoxic Activity Against Chronic Eosinophilic Leukemia

Spi-C Negatively Regulates Murine Eosinophil Differentiation

Bloodstream Progenitor-Cell Traffic In Primary Myelofibrosis Reveals Cell Subsets Showing Some Features Of Very-Small Embryonnic-Like Stem Cells (VSELs), Along With Endothelial (PEC), Mesenchymal (MPC) and Hematopoietic (HPC) Progenitor Cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only